The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: a scoping review of systematic reviews and meta-analyses

Parker Tope, Eliya Farah, Rami Ali, Mariam El-Zein, Wilson H. Miller Jr., Eduardo L. Franco
doi: https://doi.org/10.1101/2022.06.21.22276569

Article Information

doi 
https://doi.org/10.1101/2022.06.21.22276569
History 
  • June 22, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Parker Tope, BSc.1,
  2. Eliya Farah, MSc.1,
  3. Rami Ali, MSc.1,
  4. Mariam El-Zein, PhD.1,
  5. Wilson H. Miller Jr., MD.2 and
  6. Eduardo L. Franco, DrPH.1,*
  1. 1Division of Cancer Epidemiology, McGill University, Montreal, Québec, Canada
  2. 2Department of Oncology, McGill University, Montreal, Québec, Canada
  1. ↵*Correspondence: Dr. Eduardo L. Franco, eduardo.franco{at}mcgill.ca
Back to top
Posted June 22, 2022.
Download PDF

Supplementary Material

Data/Code
Email
The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: a scoping review of systematic reviews and meta-analyses
Parker Tope, Eliya Farah, Rami Ali, Mariam El-Zein, Wilson H. Miller Jr., Eduardo L. Franco
medRxiv 2022.06.21.22276569; doi: https://doi.org/10.1101/2022.06.21.22276569
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area